White matter pathology in phenylketonuria

被引:149
作者
Anderson, Peter J. [1 ,2 ]
Leuzzi, Vincenzo [3 ]
机构
[1] Univ Melbourne, Dept Psychol, Melbourne, Vic 3010, Australia
[2] Murdoch Childrens Res Inst, Melbourne, Vic, Australia
[3] Univ Roma La Sapienza, Dept Child Neurol & Psychiat, Rome, Italy
关键词
Phenylketonuria; White matter abnormality; Magnetic resonance imaging; Diffusion tensor imaging; Neuropsychological functioning; EARLY-TREATED PHENYLKETONURIA; MAGNETIC-RESONANCE-SPECTROSCOPY; OPTIMALLY CONTROLLED HYPERPHENYLALANINEMIA; NEURORADIOLOGICAL MRI CORRELATIONS; BRAIN PHENYLALANINE CONCENTRATION; IN-VIVO; EXECUTIVE FUNCTION; PREFRONTAL DYSFUNCTION; DIETARY-TREATMENT; NEUROPSYCHOLOGICAL DEFICITS;
D O I
10.1016/j.ymgme.2009.10.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Early-treated phenylketonuria (PKU) is associated with a range of neuropsychological impairments. Proposed mechanisms for these impairments include dopamine depletion and white matter pathology. Neuroimaging Studies demonstrate high-signal intensity in the periventricular white matter in most PKU patients, which can extend into subcortical and frontal regions in more severe cases. A review of histopathology and neuroimaging Studies reveals that diffuse white matter pathology in untreated PKU patients is likely to reflect hypomyelination (lack of myelin formation), while in early-treated patients white matter abnormalities observed oil magnetic resonance imaging (MRI) is likely to reflect intramyelinic edema. Research demonstrates that this pathology is associated with metabolic control and may be reversed with adherence to a strict low-phenylalanine (Phe) diet. While the functional significance of white matter pathology in PKU is not certain, there is some evidence that these abnormalities are associated with functional impairments when the pathology extends into subcortical and frontal regions. Crown Copyright (C) 2009 Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:S3 / S9
页数:7
相关论文
共 91 条
[21]   Phenylketonuria: No specific frontal lobe-dependent neuropsychological deficits of early-treated patients in comparison with diabetics [J].
Feldmann, R ;
Denecke, J ;
Pietsch, M ;
Grenzebach, M ;
Weglage, J .
PEDIATRIC RESEARCH, 2002, 51 (06) :761-765
[22]  
FILLEY C, 2001, BEHAV NEUROLOGY CERE
[23]   INTERHEMISPHERIC-TRANSFER IN CHILDREN WITH EARLY-TREATED PHENYLKETONURIA [J].
GOUROVITCH, ML ;
CRAFT, S ;
DOWTON, SB ;
AMBROSE, P ;
SPARTA, S .
JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY, 1994, 16 (03) :393-404
[24]   Executive function in treated phenylketonuria as measured by the one-back and two-back versions of the continuous performance test [J].
Griffiths, P ;
Campbell, R ;
Robinson, P .
JOURNAL OF INHERITED METABOLIC DISEASE, 1998, 21 (02) :125-135
[25]   PROTON INVIVO SPECTROSCOPY OF PATIENTS WITH HYPERPHENYLALANINEMIA [J].
HAJEK, M ;
HEJCMANOVA, L ;
PRADNY, J .
NEUROPEDIATRICS, 1993, 24 (02) :111-112
[26]   TURNOVER OF THE FAST COMPONENTS OF MYELIN AND MYELIN PROTEINS IN EXPERIMENTAL HYPERPHENYLALANINEMIA - RELEVANCE TO TERMINATION OF DIETARY-TREATMENT IN HUMAN PHENYLKETONURIA [J].
HOMMES, FA ;
ELLER, AG ;
TAYLOR, EH .
JOURNAL OF INHERITED METABOLIC DISEASE, 1982, 5 (01) :21-27
[27]   MYELIN TURNOVER IN HYPERPHENYLALANINEMIA - A REEVALUATION WITH THE HPH-5 MOUSE [J].
HOMMES, FA ;
MOSS, L .
JOURNAL OF INHERITED METABOLIC DISEASE, 1992, 15 (02) :243-251
[28]   Inhibition of prepotent responding and attentional flexibility in treated phenylketonuria [J].
Huijbregts, S ;
de Sonneville, L ;
Licht, R ;
Sergeant, J ;
van Spronsen, FA .
DEVELOPMENTAL NEUROPSYCHOLOGY, 2002, 22 (02) :481-499
[29]   Sustained attention and inhibition of cognitive interference in treated phenylketonuria: associations with concurrent and lifetime phenylalanine concentrations [J].
Huijbregts, SCJ ;
de Sonneville, LMJ ;
Licht, R ;
van Spronsen, FJ ;
Verkerk, PH ;
Sergeant, JA .
NEUROPSYCHOLOGIA, 2002, 40 (01) :7-15
[30]   The neuropathology of phenylketonuria: human and animal studies [J].
Huttenlocher, PR .
EUROPEAN JOURNAL OF PEDIATRICS, 2000, 159 (Suppl 2) :S102-S106